# Bioequivalence Study betweenYHP2406 and YHR2501 in Healthy Subjects

> **NCT06920719** · PHASE1 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 64 (actual)

## Conditions studied

- Healthy Subject

## Interventions

- **DRUG:** YHP2406
- **DRUG:** YHR2501

## Key facts

- **NCT ID:** NCT06920719
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-06-29
- **Primary completion:** 2025-07-01
- **Final completion:** 2025-07-09
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2025-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06920719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06920719, "Bioequivalence Study betweenYHP2406 and YHR2501 in Healthy Subjects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06920719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*